Researcher.Life Logo

Journal of Clinical Pharmacology : Impact Factor & More

eISSN: 1552-4604pISSN: 0091-2700

Aims and Scope of Journal of Clinical Pharmacology

The Journal of Clinical Pharmacology is a peer-reviewed medical journal that covers the field of pharmacology. The editor-in-chief is Joseph S. Bertino, Jr. (Bertino Consulting). It was established in 1961 and is currently published by John Wiley & Sons in association with the American College of Clinical Pharmacology. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.98
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Clinical Pharmacology

Journal of Clinical Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1961
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Clinical Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Clinical Pharmacology

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of DISC-3405, a Novel Recombinant Humanized Monoclonal Antibody Targeting TMPRSS6, in Adult Healthy Volunteers.
  • 1 May 2026
  • Journal of clinical pharmacology
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes.
  • 1 May 2026
  • Journal of clinical pharmacology
Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir.
  • 1 May 2026
  • Journal of clinical pharmacology
Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications.
  • 1 May 2026
  • Journal of clinical pharmacology
First-in-Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle-Specific Kinase Agonist Adimanebart (ARGX-119).
  • 1 May 2026
  • Journal of clinical pharmacology
170 Years of Mitochondrial Research and the Emergence of Mitochondrial Medicine.
  • 1 May 2026
  • Journal of clinical pharmacology
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of DISC-3405, a Novel Recombinant Humanized Monoclonal Antibody Targeting TMPRSS6, in Adult Healthy Volunteers.
  • 1 May 2026
  • Journal of clinical pharmacology
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes.
  • 1 May 2026
  • Journal of clinical pharmacology
Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir.
  • 1 May 2026
  • Journal of clinical pharmacology
Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications.
  • 1 May 2026
  • Journal of clinical pharmacology
First-in-Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle-Specific Kinase Agonist Adimanebart (ARGX-119).
  • 1 May 2026
  • Journal of clinical pharmacology
170 Years of Mitochondrial Research and the Emergence of Mitochondrial Medicine.
  • 1 May 2026
  • Journal of clinical pharmacology

FAQs on Journal of Clinical Pharmacology